Table 1. The relative performance of serological tests against statutory ante-mortem tests.
Test type | n | Comparator | P-value | AUC | Sens | Spec | PPV | NPV | Prev. (comparator) a | Test prev. b |
---|---|---|---|---|---|---|---|---|---|---|
ENFER 2ag | 919 | Skin test | 0.008 | 0.52 | 7.44% | 97.40% | 30.00% | 87.40% | 13% | 3.26% |
ENFER 2ag | 920 | IFNγ | 0.009 | 0.52 | 5.22% | 98.00% | 63.30% | 61.20% | 40% | 3.26% |
ENFER 4ag | 919 | Skin test | 0.012 | 0.52 | 4.13% | 99.00% | 38.50% | 87.20% | 13% | 1.41% |
ENFER 4ag | 920 | IFNγ | 0.013 | 0.51 | 2.75% | 99.50% | 76.90% | 61.00% | 40% | 1.41% |
IDEXX | 921 | Skin test | 0.008 | 0.53 | 9.09% | 96.40% | 27.50% | 87.50% | 13% | 4.34% |
IDEXX | 922 | IFNγ | 0.091 | 0.51 | 5.75% | 96.60% | 52.50% | 61.00% | 40% | 4.34% |
Skin test: SICCT standard interpretation.
aPrev. (comparator): the prevalence of the respective comparator, e.g. skin test etc.
b Test prev.: the prevalence of the serological test being reported e.g. ENFER 2ag